International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
The DePASS initiative in healthcare access units: Do not miss the opportunity to detect HIV, HBV, and HCV.
СтатьяНаблюдательное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Todesco Eve, Lambert-Niclot Sidonie, Maylin Sarah, Scanvion Adeline, André-Garnier Elisabeth, Leroy Pierre, Benez Pariente Karine, Saune Sandres Karine, Berthier Maude, Domenach Icard Vinca, Lovery Hélène, Parmeland Laurence, Elmouden Mohamed, Vermeulen Hervé, Soulet De Brugiere Laure, Scholtes Caroline, Larrat Sylvie, Toussaint Clément, Adami Bruno, De Monte Anne, Fartaoui Nadia, Alloui Chakib, Durand François, Poupon-Ferron Sophie, Bui Eida, Aparicio Caroline
Аннотация
OBJECTIVES: HIV, HBV, and HCV infections remain major public health concerns, particularly among vulnerable populations. Free-of-charge healthcare units provide essential care for individuals facing barriers to healthcare. However, systematic testing remains inconsistent. The DePASS initiative aimed to promote routine screening, assess infection seroprevalences, and identify barriers and facilitators to implementation.
METHODS: This multicenter prospective observational study was conducted in 12 free-of-charge healthcare units across mainland France. Staff received training on HIV/HBV/HCV screening. Over a 9-month period, units offered HIV/HBV/HCV testing to all attendees, with HDV testing for HBV-positive individuals. Diagnoses and linkage to care were quantitatively assessed. A qualitative survey explored feasibility, acceptability, and perceived barriers among staff.
RESULTS: Between December 2022 and May 2024, 6602 individuals were tested. Seroprevalence was 1.76% for HIV, 2.32% for HCV, and 5.76% for HBV; 6.53% of HBV-positive individuals also tested positive for HDV. Among those with HIV, 90.4% were linked to care. Staff cited logistical constraints, limited time, and language barriers as major challenges.
CONCLUSIONS: Systematic HIV/HBV/HCV testing yielded diagnosis rates 7 to 9 times higher than those estimated in the general French population. Scaling up this model, combined with staff training and structural support, could substantially reduce undiagnosed infections in vulnerable people.
METHODS: This multicenter prospective observational study was conducted in 12 free-of-charge healthcare units across mainland France. Staff received training on HIV/HBV/HCV screening. Over a 9-month period, units offered HIV/HBV/HCV testing to all attendees, with HDV testing for HBV-positive individuals. Diagnoses and linkage to care were quantitatively assessed. A qualitative survey explored feasibility, acceptability, and perceived barriers among staff.
RESULTS: Between December 2022 and May 2024, 6602 individuals were tested. Seroprevalence was 1.76% for HIV, 2.32% for HCV, and 5.76% for HBV; 6.53% of HBV-positive individuals also tested positive for HDV. Among those with HIV, 90.4% were linked to care. Staff cited logistical constraints, limited time, and language barriers as major challenges.
CONCLUSIONS: Systematic HIV/HBV/HCV testing yielded diagnosis rates 7 to 9 times higher than those estimated in the general French population. Scaling up this model, combined with staff training and structural support, could substantially reduce undiagnosed infections in vulnerable people.